SAN DIEGO, Feb. 22, 2017 -- Independent authenticity tests prove that Next Generation Labs TFN nicotine is wholly synthetic, while competitor product HiLIQ NTN nicotine is not synthetic, and is actually derived from tobacco.
A suite of validated scientific tests involving High Performance Liquid Chromatography (HPLC), Carbon Dating and nicotine isomer optical rotation, indicate that NTN nicotine - manufactured and sold by Chinese company HiLIQ – in NOT synthetic nicotine, but is a distilled form of tobacco-derived nicotine.
Interest in synthetic nicotine has grown rapidly in the vape industry and as a result there is a growing demand for synthetic products from manufacturers and adult consumers alike. This growing demand has resulted in a rise of nicotine products being marketed and sold as synthetic – in the interest of consumer confidence and fair market competition, Next Generation Labs funded the development of a suite of replicable authenticity tests to differentiate and validate truly synthetic against tobacco-derived nicotine.
“It’s our goal to protect the synthetic nicotine market, and after receiving a number of concerned calls from our trade customers regarding HiLiQ NTN nicotine, we felt a responsibility to take action that would either prove the validity of the NTN product claims, or reveal it as a falsely marketed product,” commented Vincent Schuman, CEO of Next Generation Labs. “Unfortunately NTN failed all of the tests – the results are clear, HiLiQ NTN is not synthetic nicotine, it is derived from tobacco.” Next Generation Labs’ test results are supported and further verified by a separate third party test conducted by Enthalpy, which also revealed HiLiQ NTN nicotine is tobacco-derived.
Schuman adds: “Synthetic nicotine allows for a vape market that is completely disassociated from tobacco, we want to make sure adult consumers have confidence in the products they are purchasing – fake products only confuse the market, the consumer and the regulator, and will damage the reputation of validated synthetic nicotine brands such as TFN.”
Next Generation Labs urges e-liquid manufacturers to be cautious when considering synthetic nicotine products that have not been test-verified. The company has opened access to the methodology for its authenticity test and asks e-liquid manufacturers to contact Next Generation Labs ([email protected]) if they have concerns, or wish to test any product marketed as synthetic nicotine.
The full analysis and results of Next Generation Labs’ and Enthalpy’s testing can be found here: http://www.nextgenerationlabs.com/ntn-from-hiliq-proved-not-to-be-synthetic-nicotine/
About Next Generation Labs
Founded in 2014, Next Generation Labs developed TFN Nicotine®, the world’s leading synthetic nicotine that is not derived from tobacco. TFN Nicotine is used in over 40 e-liquid brands in the US and is playing a central role in revolutionizing the e-cigarette and vaping industry.
Contacts Katie Ray [email protected] 973 570 6907 Ron Tully [email protected] 973 668 3887


Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 



